Tennis: Sharapova Fails Drug Test


Maria Sharapova announced she failed a drug test at the Australian Open in a press conference Monday in Los Angeles.

Sharapova was informed by the International Tennis Federation that she tested positive for Meldonium, which was added to the World Anti-Doping Agency’s list of banned substances on Jan. 1, 2016. Sharapova said she has legally been taking the drug for 10 years. Maria Sharapova Sharapova did not disclose what penalty she will face for the positive test.

Maria Sharapova



“I made a huge mistake,” Sharapova said. “I don’t want to end my career this way.”

The drug was added to WADA’s banned list as it showed “evidence of its use by athletes with the intention of enhancing performance.” Melodonium is a drug used clinically to treat angina, myocardial infarction and chronic heart failure. Her parents were also in attendance.

Follow us on twitter:

Leave a Reply